Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Assets Average (2017 - 2020)

Trinity Biotech (TRIB) has disclosed Assets Average for 4 consecutive years, with $130.7 million as the latest value for Q4 2020.

  • Quarterly Assets Average fell 7.52% to $130.7 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $130.7 million through Dec 2020, down 7.52% year-over-year, with the annual reading at $81.4 million for FY2024, 7.38% up from the prior year.
  • Assets Average hit $130.7 million in Q4 2020 for Trinity Biotech, down from $141.4 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $221.3 million in Q4 2017 to a low of $130.7 million in Q4 2020.
  • Historically, Assets Average has averaged $166.4 million across 4 years, with a median of $156.8 million in 2018.
  • Biggest five-year swings in Assets Average: fell 22.13% in 2018 and later fell 7.52% in 2020.
  • Year by year, Assets Average stood at $221.3 million in 2017, then dropped by 22.13% to $172.3 million in 2018, then fell by 17.96% to $141.4 million in 2019, then dropped by 7.52% to $130.7 million in 2020.
  • Business Quant data shows Assets Average for TRIB at $130.7 million in Q4 2020, $141.4 million in Q4 2019, and $172.3 million in Q4 2018.